Skip to main content

MARSHALL WACE, LLP

Position in ARVN — Arvinas, Inc.

CIK 1318757 LONDON, X0

Position in ARVN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$796,727
-$3,147,137 QoQ
Shares Held
75,163
-77.4% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ARVN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ARVN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $796,727 75,163
2025-12-31 $3,943,864 332,535
2025-09-30 $2,026,933 237,903
2025-06-30 $1,226,757 166,679
2025-03-31 $143,832 20,489
2024-12-31 $5,138,057 268,026
2024-09-30 $4,195,720 170,350
2024-06-30 $537,724 20,200
2023-12-31 $1,937,236 47,066
2023-06-30 $767,037 30,904
2023-03-31 $261,452 9,570
2022-06-30 $1,482,409 35,220
2021-06-30 $39,358,319 511,147
2021-03-31 $57,325,687 867,257
2020-12-31 $73,303,677 863,107
2020-09-30 $2,270,691 96,175
2020-06-30 $1,255,972 37,447